Learn more →
Back to Expert Scholars
Immunotherapy / 免疫治疗Cancer Vaccines

Elizabeth M. Jaffee

M.D.

🏢Johns Hopkins University🌐USA

Deputy Director, Sidney Kimmel Comprehensive Cancer Center

1
Key Papers
2
Key Contributions

👥Biography 个人简介

Elizabeth Jaffee is a leader in cancer vaccine development with particular focus on pancreatic cancer. Her laboratory has developed GVAX, a granulocyte-macrophage colony-stimulating factor (GM-CSF)-secreting tumor cell vaccine, and combination strategies to overcome immunosuppression in pancreatic cancer. Jaffee's work has advanced understanding of how to convert immunologically "cold" tumors to "hot" tumors.

Elizabeth Jaffee是癌症疫苗开发的领导者,特别关注胰腺癌。她的实验室开发了GVAX,一种分泌粒细胞-巨噬细胞集落刺激因子(GM-CSF)的肿瘤细胞疫苗,以及克服胰腺癌免疫抑制的组合策略。Jaffee的工作推进了如何将免疫学"冷"肿瘤转化为"热"肿瘤的理解。

Share:

🧪Research Fields 研究领域

Pancreatic Cancer胰腺癌
Cancer Vaccines癌症疫苗
Tumor Immunology肿瘤免疫学

🎓Key Contributions 主要贡献

GVAX Development

Developed GM-CSF-secreting tumor cell vaccines for pancreatic cancer.

Combination Strategies

Pioneered vaccine plus checkpoint inhibitor combinations.

Representative Works 代表性著作

[1]

Immunotherapy of pancreatic cancer with GVAX vaccines

Journal of Clinical Investigation (2010)

Clinical development of pancreatic cancer vaccines.

📄Data Sources 数据来源

Last updated: 2026-03-04 | All information from publicly available academic sources

关注 Elizabeth M. Jaffee 的研究动态

Follow Elizabeth M. Jaffee's research updates

留下邮箱,当我们发布与 Elizabeth M. Jaffee(Johns Hopkins University)相关的新研究或访谈时,我们会通知你。

我们不会泄露你的信息,也不会发送无关内容。随时可以退订。

Explore More Experts

Discover the researchers shaping the future of cancer treatment